Statistics show that out of five thousand compounds with initial promise, five will go into human clinical trials, and only one will become an approved drug. This tiny fraction illustrates the huge complexities involved in bringing a drug to market, a process that brings together scientific research, medical ethics, business, and various regulatory agencies.- A helpful listing of current FDA and European guidelines
- A special section on regulatory authorities and processes in Japan and China
- Rich illustrations throughout, including more than ninety figures and tables
- Useful appendices on the history of drug discovery and development
- Representative examples of drug mechanisms in action
Written for professionals in the pharmaceutical industry, and readily accessible for students of pharmacy or medicine and others interested in drug discovery, Drugs-From Discovery to Approval represents a practical and approachable reference on this important process.
Related posts:
- New Drug Approval Process (Drugs and The Pharmaceutical Sciences; Vol 190)
- New Drug Development: Regulatory Paradigms for Clinical Pharmacology and Biopharmaceutics (Drugs and the Pharmaceutical Sciences)
- Pharmacogenomics in Drug Discovery and Development
- FDA Regulatory Affairs : A Guide for Prescription Drugs, Medical Devices, and Biologics 2nd Edition
- Sun Pharma Announces USFDA Approval For Generic Flomax(R)
Join hundreds of students and get all book resources for FREE! Subscribe to Pharmacy E-books via RSS or via E-mail
